The Dual Eligible Coalition

Featured Speakers

D.C. Direct: Keeping you up to date on federal health policy and politics. What happens in Washington will impact virtually every health care organization. Congress and the Administration debate significant, paradigm-changing health care policies that impact how care is delivered, financed, and priced; how we improve public health; and how to incorporate new tools and … Read more

Terms of Use TERMS OF USE Last updated:  January 11, 2021 Leavitt Partners, LLC and its affiliates (“Leavitt Partners” or “we”) provides its content on its websites or applications that post a link to this Terms of Use (the “Site”) subject to the following terms and conditions (the “Terms”). W We reserve the right, in … Read more

How We Help With Public Health Organizations Leavitt Partners’ experts have decades of experience working in the private and public health sectors as well as in the executive and legislative branches of the government. In response to this pandemic, Leavitt Partners has developed services to help clients address today’s urgency, while preparing for the new … Read more

How We Help Providers How We Help Providers Leavitt Partners offers a seasoned team of health care leaders and policy experts to support providers during every stage of their transition to value-based payment models, from the time they are considering the transformation – to researching the dynamics of their local market – to developing and … Read more

How We Help Payers Leavitt Partners specializes in analytics, policy interpretation, strategy support, and market intelligence, that position payers for success amidst a rapidly changing health care landscape. Leavitt Partners also convenes industry leaders to share experiences, benchmark against industry averages, and learn from one another’s insights. Why We’re Different Leavitt Partners industry expertise, deep … Read more

How We Help Life Sciences Companies Leavitt Partners experts have decades of combined experience working on sophisticated biotechnology, pharmaceutical, and medical device issues in former leadership roles within the public and private sector. Our team synthesizes technical regulatory issues, policy dynamics, and business implications to help life sciences clients succeed, both domestically and internationally. Why … Read more

How We Help Investors Despite some political and macroeconomic uncertainty, health care and life sciences sectors will continue to demonstrate high investment interest and activity, primarily due to reliable demand for patient care by an aging population with a significant and growing disease burden. Successful health care organizations will see the strategic imperative to find … Read more